Organovo Holdings Inc: More than doubles on kidney disease tie-up
30/05/2019 15:28
** 3D human tissue printer's shares ONVO.O more than
double to 84 cents in heavy volumes - second-most actively
traded stock and biggest percentage gainer across U.S. exchanges
** Co says collaborating with Murdoch Children's Research
Institute (MCRI) in Australia and Universiteit Leiden (LUMC) in
Netherlands to expand the use of 3D printed therapeutic tissues
for treating end-stage kidney disease urn:newsml:reuters.com:*:nGNX9cC4NQ
** The tie-up aims to use Organovo's bioprinting platform
with MCRI's stem cell differentiation technology and LUMC's
clinical expertise - ONVO
** More than 18 mln shares have changed hands, nearly 15
times their 25-day moving avg
** Thursday's rise set to cut YTD losses to ~9%; stock had
fallen ~39% earlier this month after co announced a delay in
liver tissue asset development
(Reporting by Manas Mishra in Bengaluru)
((Reuters Messaging:
manas.mishra.thomsonreuters.com@reuters.net))